Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 3
1958 1
1961 1
1967 2
1968 1
1970 1
1971 4
1972 2
1973 4
1974 3
1975 1
1976 2
1977 1
1978 1
1979 2
1980 1
1981 1
1982 4
1983 4
1984 3
1985 2
1986 1
1987 4
1989 3
1990 2
1991 5
1992 3
1993 5
1994 3
1995 7
1996 5
1997 5
1998 6
1999 4
2000 8
2001 5
2002 8
2003 10
2004 9
2005 13
2006 19
2007 16
2008 17
2009 15
2010 9
2011 9
2012 13
2013 9
2014 11
2015 16
2016 24
2017 16
2018 10
2019 21
2020 15
2021 16
2022 13
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

363 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM; SENSCIS Trial Investigators. Distler O, et al. N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Free article. Clinical Trial.
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.
Fizazi K, Piulats JM, Reaume MN, Ostler P, McDermott R, Gingerich JR, Pintus E, Sridhar SS, Bambury RM, Emmenegger U, Lindberg H, Morris D, Nolè F, Staffurth J, Redfern C, Sáez MI, Abida W, Daugaard G, Heidenreich A, Krieger L, Sautois B, Loehr A, Despain D, Heyes CA, Watkins SP, Chowdhury S, Ryan CJ, Bryce AH; TRITON3 Investigators. Fizazi K, et al. N Engl J Med. 2023 Feb 23;388(8):719-732. doi: 10.1056/NEJMoa2214676. Epub 2023 Feb 16. N Engl J Med. 2023. PMID: 36795891 Free PMC article. Clinical Trial.
Acute sacroiliitis.
Slobodin G, Rimar D, Boulman N, Kaly L, Rozenbaum M, Rosner I, Odeh M. Slobodin G, et al. Among authors: rosner i. Clin Rheumatol. 2016 Apr;35(4):851-6. doi: 10.1007/s10067-016-3200-6. Epub 2016 Feb 4. Clin Rheumatol. 2016. PMID: 26847855 Review.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R, Mysler E, Hall S, Kivitz AJ, Moots RJ, Luo Z, DeMasi R, Soma K, Zhang R, Takiya L, Tatulych S, Mojcik C, Krishnaswami S, Menon S, Smolen JS; ORAL Strategy investigators. Fleischmann R, et al. Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16. Lancet. 2017. PMID: 28629665 Clinical Trial.
Acute Gout Sacroiliitis.
Kaly L, Bilder I, Rozenbaum M, Boulman N, Rimar D, Awisat A, Rosner I, Hussein H, Silawy A, Gaspar T, Slobodin G. Kaly L, et al. Among authors: rosner i. Isr Med Assoc J. 2021 Mar;23(3):191-192. Isr Med Assoc J. 2021. PMID: 33734634 Free article. No abstract available.
Sacroiliitis - early diagnosis is key.
Slobodin G, Hussein H, Rosner I, Eshed I. Slobodin G, et al. Among authors: rosner i. J Inflamm Res. 2018 Sep 10;11:339-344. doi: 10.2147/JIR.S149494. eCollection 2018. J Inflamm Res. 2018. PMID: 30237730 Free PMC article. Review.
Giant Cell Arteritis: State of the Art in Diagnosis, Monitoring, and Treatment.
Awisat A, Keret S, Silawy A, Kaly L, Rosner I, Rozenbaum M, Boulman N, Shouval A, Rimar D, Slobodin G. Awisat A, et al. Among authors: rosner i. Rambam Maimonides Med J. 2023 Apr 30;14(2):e0009. doi: 10.5041/RMMJ.10496. Rambam Maimonides Med J. 2023. PMID: 37116064 Free PMC article. Review.
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun JB, Levy Y, Leszcyzński P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP; RESOLVE-1 Study Group. Spiera R, et al. Arthritis Rheumatol. 2023 Sep;75(9):1608-1618. doi: 10.1002/art.42510. Epub 2023 Jun 15. Arthritis Rheumatol. 2023. PMID: 37098795 Free article. Clinical Trial.
363 results